PIR promotes tumorigenesis of breast cancer by upregulating cell cycle activator E2F1
- 10 September 2019
- journal article
- research article
- Published by Taylor & Francis in Cell Cycle
- Vol. 18 (21) , 2914-2927
Abstract
Pirin (PIR) protein belongs to the superfamily of cupin and is highly conserved between eukaryotic and prokaryotic organisms. It has been reported that PIR is upregulated in various tumors and involved in tumorigenesis. However, its biological functions particularly in promoting tumorigenesis are, to date, poorly characterized. Here we report that knockdown of PIR in MCF7 and MDA-MB-231 cell lines causes a dramatic decrease in cell proliferation and xenograft tumor growth in mice. Mechanistically, the cell cycle activator E2F1 and its target genes cdk4, cdk6, cycE, cycD and DDR1 are remarkably downregulated in PIR depleted cells, leading to G1/S phase arrest. Luciferase reporter assay and chromatin immunoprecipitation assay indicate that PIR can activate E2F1 transcription by binding to its promoter region. Consistent with the observation in PIR knockdown cells, PIR inhibitors markedly inhibit the proliferation of both cell lines. Furthermore, knockdown of PIR significantly decreases the abilities of MCF7 cells for mobility and invasion in vitro and their metastasis in mice, which may be attributed to the decrease of DDR1. In conclusion, PIR stimulates tumorigenesis and progression by activating E2F1 and its target genes. Our finding thus suggests PIR as a potential druggable target for the therapy of cancers with high expression level of PIR.Keywords
Funding Information
- by the National Natural Science Foundation of China (91857102, U1705287, 31571473 and 31701252)
- State Key Laboratory of Cellular Stress Biology, Xiamen University (SKLCSB2018KF007)
This publication has 28 references indexed in Scilit:
- Wide-ranging functions of E2F4 in transcriptional activation and repression revealed by genome-wide analysisNucleic Acids Research, 2011
- A small-molecule inhibitor shows that pirin regulates migration of melanoma cellsNature Chemical Biology, 2010
- E2f1–3 switch from activators in progenitor cells to repressors in differentiating cellsNature, 2009
- Basal Cancer Cell Survival Involves JNK2 Suppression of a Novel JNK1/c-Jun/Bcl-3 Apoptotic NetworkPLOS ONE, 2009
- E2F7 Can Regulate Proliferation, Differentiation, and Apoptotic Responses in Human Keratinocytes: Implications for Cutaneous Squamous Cell Carcinoma FormationCancer Research, 2009
- Down-regulation of CYLD expression by Snail promotes tumor progression in malignant melanomaJournal of Experimental Medicine, 2009
- Comparative Analysis of E2F Family Member Oncogenic ActivityPLOS ONE, 2007
- Mutations in the NF-κB signaling pathway: implications for human diseaseOncogene, 2006
- Drosophila E2F1 Has Context-Specific Pro- and Antiapoptotic Properties during DevelopmentDevelopmental Cell, 2005
- Combination of microdissection and microarray analysis to identify gene expression changes between differentially located tumour cells in breast cancerOncogene, 2003